CPRX — CATALYST PHARMACEUTICALS INC

Ownership history in NATIXIS  ·  4 quarters on record

This page tracks every 13F SEC filing in which NATIXIS reported a position in CATALYST PHARMACEUTICALS INC (CPRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.01% (2023 Q3)
Avg. % of fund
0.01%
First filed
2021 Q4
Last filed
2025 Q3
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 REDUCED 87,572 -20,728 -19.1% 0.01% $1.7M $19.70
2023 Q3 REDUCED 108,300 -117,077 -51.9% 0.01% $1.3M $11.69
2022 Q1 REDUCED 225,377 -10,643 -4.5% 0.01% $1.9M $8.29
2021 Q4 INITIATED 236,020 — — 0.01% $1.6M $6.77
% of Fund (quarterly)    CPRX price (monthly, adj. close)

Other funds also holding CPRX

As of 2025 Q4 — sorted by position size

TANAKA CAPITAL MANAGEMENT INC 3Y 7Y 4.87% GABLES CAPITAL MANAGEMENT INC. 3Y 7Y 4.19% JW Asset Management, LLC 3Y 7Y 2.95% Knott David M Jr 3Y 2.04% DEERFIELD MANAGEMENT COMPANY, L.P. 3Y 7Y 1.46% QSV Equity Investors LLC 1.24% Bridge City Capital, LLC 3Y 7Y 1.07% GLOBEFLEX CAPITAL L P 3Y 7Y 1.04% JUNCTURE WEALTH STRATEGIES, LLC 3Y 7Y 0.65% KENNEDY CAPITAL MANAGEMENT LLC 3Y 7Y 0.6%
← Back to NATIXIS Holdings